Dextro-transposition of the great arteries follow up: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 9: Line 9:




The American College of Cardiology/American Heart Association (ACC/AHA) classification of the recommendations for patient evaluation and treatment (classes I-III) and the levels of evidence (A-C) are defined at the end of the "Major Recommendations" field.
'''The American College of Cardiology/American Heart Association (ACC/AHA) classification of the recommendations for Endocarditis Prophylaxsis'''


{{cquote|
{{cquote|

Revision as of 16:37, 12 August 2011

Dextro-transposition of the great arteries/complete transposition of the great arteries Microchapters

Home

Patient Info

Overview

Pathophysiology

Epidemiology & Demographics

Screening

Natural History, Complications & Prognosis

Causes of dextro-transposition of the great arteries

Differentiating dextro-transposition of the great arteries from other Diseases

Diagnosis

History & Symptoms

Physical Examination

Lab Tests

Electrocardiogram

Chest X Ray

Echocardiography or Ultrasound

Cardiac catheterization

Treatment overview

Medical Therapy

Transposition of the great arteries

Transposition of the great arteries

Transposition of the great arteries

Transposition of the great vessels Microchapters

Home

Patient Information

Overview

Historical perspective

Classification

Dextro-transposition of the great arteries
L-transposition of the great arteries

Pathophysiology

Causes

Differentiating Transposition of the great vessels from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

MRI

CT

Echocardiography

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Palliative care
Corrective surgery
Post-operative care
Follow up

Prevention

Reproduction

Case Studies

Case #1

Dextro-transposition of the great arteries follow up On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Dextro-transposition of the great arteries follow up

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Dextro-transposition of the great arteries follow up

CDC on Dextro-transposition of the great arteries follow up

Dextro-transposition of the great arteries follow up in the news

Blogs on Dextro-transposition of the great arteries follow up

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Dextro-transposition of the great arteries follow up

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Priyamvada Singh, M.B.B.S. [2]; Cafer Zorkun, M.D., Ph.D. [3]; Keri Shafer, M.D. [4]; Assistant Editor(s)-In-Chief: Kristin Feeney, B.S. [5]

Overview

Major Recommendations [1](DONOT EDIT)


The American College of Cardiology/American Heart Association (ACC/AHA) classification of the recommendations for Endocarditis Prophylaxsis

Key Issues to Evaluate and Follow-Up Recommendations for Endocarditis Prophylaxis Class IIa

  • Antibiotic prophylaxis before dental procedures that involve manipulation of gingival tissue or the periapical region of teeth or perforation of the oral mucosa is reasonable in those with the following indications:
    • Prosthetic cardiac valve. (Level of Evidence: B)
    • Previous infective endocarditis (IE). (Level of Evidence: B)
    • Unrepaired and palliated cyanotic CHD, including surgically constructed palliative shunts and conduits. (Level of Evidence B)
    • Completely repaired CHD with prosthetic materials, whether placed by surgery or by catheter intervention, during the first 6 months after the procedure. (Level of Evidence: B)
    • Repaired CHD with residual defects at the site or adjacent to the site of a prosthetic patch or prosthetic device that inhibit endothelialization. (Level of Evidence: B)
  • It is reasonable to consider antibiotic prophylaxis against IE before vaginal delivery at the time of membrane rupture in select patients with the highest risk of adverse outcomes. This includes patients with the following indications:
    • Prosthetic cardiac valve or prosthetic material used for cardiac valve repair. (Level of Evidence: C)
    • Unrepaired and palliated cyanotic CHD, including surgically constructed palliative shunts and conduits. (Level of Evidence: C)

Class III

  • Prophylaxis against IE is not recommended for nondental procedures (such as esophagogastroduodenoscopy or colonoscopy) in the absence of active infection. (Level of Evidence: C)

Recommendation for Reproduction

  • Before women with d-TGA contemplate pregnancy, a comprehensive clinical, functional, and echocardiographic evaluation should be performed at a center with expertise in ACHD. (Level of Evidence: C)
  1. Warnes CA, Williams RG, Bashore TM, Child JS, Connolly HM, Dearani JA; et al. (2008). "ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons". J Am Coll Cardiol. 52 (23): e1–121. doi:10.1016/j.jacc.2008.10.001. PMID 19038677.